Trials / Completed
CompletedNCT01668199
A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101
An Open-Label, Single-Dose, Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Norgine · Industry
- Sex
- Male
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A study to investigate the mass balance recovery and pharmacokinetics of 14C TZP-101.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TZP-101 |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-02-01
- Completion
- 2012-03-01
- First posted
- 2012-08-17
- Last updated
- 2012-08-17
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01668199. Inclusion in this directory is not an endorsement.